News and Announcements
Proteomics March Update: PromarkerD Progress, Indian Biotech Market Expansion & Solid Quarter Results
- Published April 26, 2016 11:48AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th April 2016, ASX Announcement
Life sciences company Proteomics International Laboratories Ltd (ASX:PIQ) (the Company, PILL) is pleased to provide the following update on its business activities for the three month period to 31 March 2016.
Highlights
- PromarkerD progress: 500 patient follow-up validation study underway to further validate PromarkerD’s initial ground-breaking results.
- IVD test kit for PromarkerD: Assessing development program to produce a clinical pathology In Vitro Diagnostic (IVD) test kit for PromarkerD.
- Therapeutic Drug Discovery Program: to discover new analgesic and antibiotics drug compounds.
- Analytical Services operations: Solid quarter-on-quarter results.
- Business Development: Company expands operations in massive Indian biotech market.
The March quarter delivered another period of sound performance for PILL. During the quarter, it embarked on a number of programs utilising its proprietary, disruptive technology platform. This included a development program, to produce a standard clinical pathology In Vitro Diagnostic (IVD) test kit for PromarkerD.
To view the full article, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
